View Archive »
About The Cover
Fusion of 3T3 or p53-/- 3T3 fibroblasts. At 6 h after fusion, the cells were fixed and centrosomes were visualized with immunostaining for γ-tubulin. The nuclei were stained with DAPI. See Chui Chui Ho et al. The requirement of p53 for maintaining chromosomal stability during tetraploidization (pp 583).
|
|
Table of Contents
|
| Betaadrenergic signaling a novel target for cancer therapy |
|
https://doi.org/10.18632/oncotarget.182
|
| 466-469 |
|
| A new therapeutic basis for treating LiFraumeni Syndrome breast tumors expressing mutated TP53 |
|
https://doi.org/10.18632/oncotarget.183
|
| 470-471 |
Reviews
|
| Refractory chronic lymphocytic leukemia – new therapeutic strategies |
|
https://doi.org/10.18632/oncotarget.184
|
| 472-482 |
|
| Standards and Impact of Hematopathology in Myelodysplastic Syndromes MDS |
|
https://doi.org/10.18632/oncotarget.185
|
| 483-496 |
|
| EGFRmutated lung cancer: a paradigm of molecular oncology |
|
https://doi.org/10.18632/oncotarget.186
|
| 497-514 |
|
| Antiangiogenic agents in advanced gastrointestinal malignancies: past present and a novel future |
|
https://doi.org/10.18632/oncotarget.187
|
| 515-529 |
|
| Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs |
|
https://doi.org/10.18632/oncotarget.188
|
| 530-543 |
|
| The pursuit of oncotargets through understanding defective cell regulation |
|
https://doi.org/10.18632/oncotarget.189
|
| 544-551 |
|
| Targeting Metabolic Remodeling in Glioblastoma Multiforme |
|
https://doi.org/10.18632/oncotarget.190
|
| 552-562 |
|
| Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells |
|
https://doi.org/10.18632/oncotarget.191
|
| 563-577 |
|
| Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's Macroglobulinemia |
|
https://doi.org/10.18632/oncotarget.192
|
| 578-582 |
Research Papers
|
| The requirement of p53 for maintaining chromosomal stability during tetraploidization |
|
https://doi.org/10.18632/oncotarget.193
|
| 583-595 |
|
| The Class I Hdac Inhibitor Mgcd0103 Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Initiating Cells by Upregulating Dickkopf1 and NonCanonical Wnt Signaling |
|
https://doi.org/10.18632/oncotarget.194
|
| 596-605 |
|
| Homologous recombination repair is essential for repair of vosaroxininduced DNA doublestrand breaks |
|
https://doi.org/10.18632/oncotarget.195
|
| 606-619 |
|
| Sumoylation of Vimentin354 Is Associated with PIAS3 Inhibition of Glioma Cell Migration |
|
https://doi.org/10.18632/oncotarget.196
|
| 620-627 |
|
| BetaBlocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival |
|
https://doi.org/10.18632/oncotarget.197
|
| 628-638 |
|
| Evaluation of an Actinomycin D/VX680 aurora kinase inhibitor combination in p53based cyclotherapy |
|
https://doi.org/10.18632/oncotarget.198
|
| 639-650 |
Research Perspectives
|
| Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget |
|
https://doi.org/10.18632/oncotarget.199
|
| 651-661 |
|
| Targeting tumor angiogenesis with TSP1based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors |
|
https://doi.org/10.18632/oncotarget.200
|
| 662-673 |
|
| Wnt/Î’Catenin and Sex Hormone Signaling In Endometrial Homeostasis and Cancer |
|
https://doi.org/10.18632/oncotarget.201
|
| 674-684 |
|
| Novel Insights into the Molecular Mechanisms Governing Mdm2 Ubiquitination and Destruction |
|
https://doi.org/10.18632/oncotarget.202
|
| 685-690 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
